Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | LAP3 | P28838 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL11142811 | 0.97 | SRC (0.73) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL27676341 | 0.97 | SRC (0.73) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL37038 | 0.97 | SRC (0.73) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL3961989 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| Water SCHEMBL7104000 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL23241864 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| Phosphoric Acid SCHEMBL8142468 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL11317985 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| SCHEMBL9583781 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 | |
| Phosphoric Acid SCHEMBL2168208 | 0.95 | SRC (0.70) | SRCL3MBTL1TDP1POLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796800-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2017-10-24 | — | — | US | claimed |
| US-20160108153-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2016-04-21 | — | — | US | claimed |
| US-8188201-B2 | Bulk polymerization process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2012-05-29 | — | — | US | claimed |
| US-20100004413-A1 | BULK POLYMERIZATION PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (JP) | 2010-01-07 | — | — | US | claimed |
| EP-2075266-A2 | Bulk polymerization process for producing polydienes | Bridgestone Corporation (JP) | 2009-07-01 | — | — | EP | claimed |
| EP-3969490-B1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND TIRE COMPONENTS | BRIDGESTONE CORP (JP) | 2026-03-25 | — | — | EP | disclosed |
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | GOODYEAR TIRE & RUBBER (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260002005-A1 | DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP | GOODYEAR TIRE & RUBBER (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260001974-A1 | DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP | GOODYEAR TIRE & RUBBER (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-12-25 | — | — | US | disclosed |
| US-12410263-B2 | Modified high-Cis polybutadiene polymer, related methods and rubber compositions | BRIDGESTONE AMERICAS TIRE OPERATIONS, LLC (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3883974-B1 | POLYMER COMPOSITION AND A METHOD FOR PREPARING THEREOF | SIBUR HOLDING PUBLIC JOINT STOCK CO (RU) | 2025-09-03 | — | — | EP | disclosed |
| US-6897270-B2 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2005-05-24 | — | — | US | disclosed |
| US-20050038215-A1 | Lanthanide-based catalyst composition for producing cis-1,4-polydienes | BRIDGESTONE CORPORATION (JP) | 2005-02-17 | — | — | US | disclosed |
| US-20040116638-A1 | Continuous process for the production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | BRIDGESTONE CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |
| CN-1494556-A | Continuous process for production of conjugated diene polymers having narrow molecular weight distribution and products therefrom | ������������ʽ���� | 2004-05-05 | — | — | CN | disclosed |
| US-6699813-B2 | COMPOSITION THAT IS COMBINATION OF OR REACTION PRODUCT OF LANTHANIDE COMPOUND, ALKYLATING AGENT, NICKEL-CONTAINING COMPOUND, AND OPTIONALLY HALOGEN-CONTAINING COMPOUND THAT INCLUDES ONE OR MORE LABILE HALOGEN ATOMS | BRIDGESTONE CORPORATION (JP) | 2004-03-02 | — | — | US | disclosed |
| EP-1370593-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | Bridgestone Corporation (JP) | 2003-12-17 | — | — | EP | disclosed |
| US-20030176276-A1 | Lanthanide-based catalyst composition for the manufacture of polydienes | BRIDGESTONE CORPORATION (JP) | 2003-09-18 | — | — | US | disclosed |
| WO-2002068484-A1 | CONTINUOUS PROCESS FOR THE PRODUCTION OF CONJUGATED DIENE POLYMERS HAVING NARROW MOLECULAR WEIGHT DISTRIBUTION AND PRODUCTS THEREFROM | BRIDGESTONE CORPORATION (JP) | 2002-09-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035494-A1 | METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS | ITGA1, HSPA1A, SHC1 | SRC 1344/4885L3MBTL1 709/4885TDP1 1392/4885 |
| US-20260001974-A1 | DISULFUR DICHLORIDE AND SILANE/SILOXANE ADDITIVE FOR MOONEY JUMP | DCLRE1A, DDR1, FDFT1 | SRC 1855/4885L3MBTL1 1317/4885TDP1 2818/4885 |
| US-20260002005-A1 | DISULFUR DICHLORIDE AND ALKENYL ETHERS ADDITIVES FOR MOONEY JUMP | MRE11, DDR1, DDB1 | SRC 1830/4885L3MBTL1 613/4885TDP1 2025/4885 |
| US-20250389555-A1 | MODIFIED HIGH-CIS POLYBUTADIENE POLYMER, RELATED METHODS AND RUBBER COMPOSITIONS | MALT1, INO80C, RTCB | SRC 2447/4885L3MBTL1 212/4885TDP1 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.